Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H25N3O5S2 |
InChIKeyKXWBUKMWZKTHCV-UHFFFAOYSA-N |
CAS Registry940943-37-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 01 May 2008 |